Home  /  Resource Library  /  Antibody Response after One and/or Two Doses of BNT162b2 Anti-Sars-Cov-2 mRNA Vaccine in Patients Treated By CAR T-Cells Therapy

Antibody Response after One and/or Two Doses of BNT162b2 Anti-Sars-Cov-2 mRNA Vaccine in Patients Treated By CAR T-Cells Therapy

ASH 2021